DNA與RNA合成研究綜述：2025年

全球 DNA 讀取、寫入和編輯市場預計在 2025 年達到 259 億美元，預計從 2025 年到 2030 年將以 21.2% 的複合年成長率成長，到 2030 年達到 677 億美元。

全球DNA法醫學市場預計將從2025年的約33億美元成長到2030年底的47億美元，2025年至2030年的複合年成長率為7.7%。

全球表觀遺傳學研究工具和試劑、體外診斷 (IVD) 產品和治療藥物市場預計將從 2024 年的 48 億美元成長到 2029 年底的 85 億美元，2024 年至 2029 年的複合年成長率為 11.8%。

DNA和RNA合成是指人工合成去氧核糖核酸（DNA）和核糖核酸（RNA）。 DNA和RNA合成技術的進步極大地增進了我們對生物學的理解，並提升了我們的設計能力。目前已有多種合成DNA，包括寡核苷酸、基因以及DNA和RNA片段，並可依客戶需求進行客製化。合成DNA和RNA廣泛應用於新藥和疫苗的研發、遺傳疾病的基因治療以及分子診斷工具的開發，例如聚合酵素鏈鎖反應（PCR）檢測和用於病原體和疾病檢測的核酸感測器。

DNA和RNA合成技術在合成生物學、分子遺傳學和生物工程等科學領域至關重要，它們有助於建立客製化的DNA和RNA序列，從而廣泛應用於研究、診斷和治療領域。基因組研究的快速發展、治療性DNA和RNA應用的進步以及對個人化醫療日益成長的需求，正推動DNA和RNA合成市場顯著成長。 CRISPR、基因治療和合成生物學領域的創新表明，對DNA和RNA合成的需求激增，使其成為開發標靶治療和創新基因研究解決方案的關鍵工具。

本研究綜述重點摘錄了BCC Research關於DNA和RNA合成的2025年報告，內容涵蓋DNA讀取、寫入和編輯、DNA定序、DNA法醫學、表觀遺傳學、mRNA和基因組編輯等領域。報告總結了市場概況、市場影響因素和機會、新興技術和發展趨勢、市場規模趨勢和預測，並按不同細分市場和地區進行了詳細分析。

目錄

第1章：序言

第2章：全球DNA讀取、寫入與編輯市場（BIO193B）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 當前市場概況
• 定序技術
• 桑格定序
• 第三代定序
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 定序技術進步中的新興技術
• 定序技術的進步
• 按技術分類的市場分析
• 重點
• DNA分析（定序分析）
• DNA 寫入（合成）
• DNA編輯（基因組編輯）
• 區域市場分析
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• 從永續性到ESG觀點
• DNA讀取、寫入和編輯產業的ESG實踐
• 環境績效
• ESG風險評估
• 結論

第3章：中國DNA定序市場（BIO152C）

• 市場展望
• 調查範圍
• 市場概況
• 技術進步
• 市場動態與成長要素
• 細分市場分析
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 長讀長定序技術
• 單分子即時（SMRT）定序
• 人工智慧和機器學習在DNA定序的應用
• 按產品和服務進行市場分析
• 測量儀器和耗材
• 服務
• 中國DNA定序市場分析（依技術分類）
• 次世代定序（NGS）
• 第三代定序
• 桑格定序
• 焦磷酸定序
• 中國DNA定序市場分析（依省份分類）

第4章：全球DNA法醫學市場（BIO266A）

• 市場展望
• 調查範圍
• 市場概況
• 技術進步
• 市場動態與成長要素
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場約束
• 市場機遇
• 新興科技/最新科技/趨勢
• NGS
• NGI系統
• 市場區隔
• 重點
• 試劑盒和耗材
• 裝置
• 軟體
• 按來源分類的市場分析
• 重點
• 血
• 骨
• 頭髮
• 其他
• 按技術分類的市場分析
• 重點
• PCR擴增
• 短串聯重複序列
• 毛細管電泳
• NGS
• 其他
• 區域市場分析
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 中東和非洲
• 全球DNA法醫學產業的永續性
• ESG風險與評級：理解數據
• 關於ESG的結論

第5章：表觀遺傳學：科技與全球市場（PHM044D）

• 市場展望
• 調查範圍
• 表觀遺傳學市場概述：技術
• RNA測序市場概覽
• 表觀遺傳學概述
• DNA甲基化
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場趨勢
• 新興科技與發展
• 表觀基因編輯
• 市場區隔
• 市場概覽
• 市場規模及預測
• DNA甲基化
• 組蛋白修飾
• RNA修飾
• 區域市場
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• ESG概覽
• 表觀遺傳治療和診斷市場中的關鍵ESG問題
• 製藥生產中的永續性實踐
• 永續包裝
• 表觀遺傳學研究工具市場面臨的主要ESG挑戰
• ESG風險評估評分 - 數據解讀
• 結論

第6章 mRNA：治療藥物與全球市場（BIO212C）

• 市場展望
• 調查範圍
• 市場概況
• 市場成長要素
• 新興技術
• 新冠病毒mRNA疫苗
• 區域分析
• 結論
• 市場概覽
• RNA療法的發展
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 奈米顆粒
• 修飾的mRNA
• 市場分析
• 重點
• 新冠病毒mRNA疫苗
• 非新冠病毒mRNA疫苗及治療藥物
• 按地區分類的市場細分
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• mRNA治療產業的永續性
• ESG風險評估
• ESG績效分析
• 環境績效
• 社會表現
• 管治績效
• BCC 的結論

第7章 基因組編輯：科技與全球市場（BIO146D）

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽
• 市場動態
• 市場促進因素
• 市場約束
• 市場機遇
• 市場挑戰
• 新興技術
• CRISPR的體內遞送
• 市場區隔
• CRISPR-Cas
• TALEN
• 區域市場
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• ESG概覽
• 基因組編輯的永續性：從ESG觀點
• ESG挑戰
• ESG績效分析
• 環境績效
• 社會表現
• 管治績效
• BCC的結語

第8章 基因修飾療法的臨床應用：基因療法、基因修飾細胞療法、RNA療法、基因編輯（BIO159B）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• CRISPR的體內遞送
• 市場區隔
• 重點
• RNA療法
• 基因修飾細胞療法
• 基因治療
• 基因編輯
• 區域市場分析
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• ESG概覽
• ESG風險評估
• 結論

第9章 基於細胞的檢測：技術與全球市場 (BIO080F)

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興科技與發展
• 數據分析中的人工智慧和機器學習
• 市場區隔
• 基於細胞的檢測：全球市場
• 消耗品
• 裝置
• 軟體
• 服務
• 區域市場分析
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區
• 細胞檢測市場的永續性
• 動物實驗
• 小型化和自動化
• 綠色化學和環保材料
• 3D細胞培養與組織模型
• 減少廢棄物和最佳化資源利用
• 提高藥物發現效率
• ESG風險與評級：理解數據
• BCC的觀點

第10章附錄

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.

Report Scope

DNA and RNA synthesis artificially manufacture deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Developing synthetic techniques to construct DNA and RNA has improved the ability to understand and engineer biology. Different types of synthesized DNA, such as oligonucleotides, genes, and DNA and RNA fragments, are available and can be tailored to customer needs. Synthetic DNA and RNA are used to develop new drugs and vaccines, gene therapies for genetic disorders, and the development of molecular diagnostic tools, including polymerase chain reaction (PCR) assays and nucleic-acid-based sensors, to detect pathogens and diseases.

DNA and RNA synthesis technology is vital in scientific fields such as synthetic biology, molecular genetics, and bioengineering, creating custom DNA and RNA sequences for various research, diagnostic, and therapeutic applications. The rapid expansion of genomics research, advances in therapeutic DNA and RNA applications, and the growing need for personalized medicine are driving exceptional growth in the DNA and RNA synthesis market. The innovations in Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), gene therapy, and synthetic biology show that the demand for DNA and RNA synthesis has risen sharply, positioning it as a pivotal tool in developing targeted treatments and innovative genetic research solutions.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2025 Research Review of DNA and RNA synthesis technology provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2025:

• BIO193B Global DNA Read, Write, and Edit Market
• BIO152C The Chinese Market for DNA Sequencing
• BIO266A Global DNA Forensics Market
• PHM044D Epigenetics: Technologies and Global Markets
• BIO212C mRNA: Therapeutics and Global Markets
• BIO146D Genome Editing: Technologies and Global Markets
• BIO159B Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, and Gene Editing
• BIO080F Cell-Based Assays: Technologies and Global Markets

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Global DNA Read, Write, and Edit Market (BIO193B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Current Market Overview
• Sequencing Technologies
• Sanger Sequencing
• Third-Generation Sequencing
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies of Advances in Sequencing Technologies
• Advances in Sequencing Technologies
• Market Analysis by Technology
• Key Takeaways
• DNA Read (Sequencing)
• DNA Write (Synthesis)
• DNA Edit (Genome Editing)
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability to ESG Perspective
• ESG Practices in the DNA Read, Write, and Edit Industry
• Environmental Performance
• ESG Risk Ratings
• Conclusion

Chapter 3 The Chinese Market for DNA Sequencing (BIO152C)

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Factors
• Segmental Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Driver
• Market Restraints
• Market Opportunities
• Emerging technologies and Developments
• Long-Read Sequencing Technologies
• Single-Molecule Real-Time (SMRT) Sequencing
• Artificial Intelligence (AI) and Machine Learning in DNA Sequencing
• Market Analysis by Product and Services
• Instruments and Consumables
• Services
• Chinese DNA Sequencing Market Analysis, by Technology
• Next-Generation Sequencing (NGS)
• Third-Generation Sequencing
• Sanger Sequencing
• Pyrosequencing
• Chinese DNA Sequencing Market Analysis, by Province

Chapter 4 Global DNA Forensics Market (BIO266A)

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Drivers
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Driver
• Market Restraint
• Market Opportunities
• Emerging Technologies Newest Technologies/Trends
• NGS
• NGI System
• Market Breakdown
• Key Takeaways
• Kits and Consumables
• Equipment
• Software
• Market Analysis by Source
• Key Takeaways
• Blood
• Bones
• Hair
• Others
• Market Analysis by Technique
• Key Takeaways
• PCR Amplification
• Short Tandem Repeat
• Capillary Electrophoresis
• NGS
• Others
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Sustainability in the Global DNA Forensics Industry
• ESG Risks and Ratings: Understanding the Data
• Concluding Remarks on ESG

Chapter 5 Epigenetics: Technologies and Global Markets (PHM044D)

• Market Outlook
• Scope of Report
• Market Summary of Epigenetics: Technologies
• Market Overview of RNA Sequencing
• Epigenetics Overview
• DNA Methylation
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Trends
• Emerging Technologies and Developments
• Epigenome Editing
• Market Breakdown
• Market Overview
• Market Size and Forecast
• DNA Methylation
• Histone Modification
• RNA Modification
• Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• Key ESG Issues in Epigenetics Pharmaceuticals andDiagnostics Market
• Sustainability Practices in Pharmaceuticals Manufacturing
• Sustainable Packaging
• Key ESG Issues in Epigenetics Research Tools Market
• ESG Risk Ratings Score - Understanding the Data
• Concluding Remarks

Chapter 6 mRNA: Therapeutics and Global Markets (BIO212C)

• Market Outlook
• Scope of Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• COVID mRNA Vaccines
• Regional Analysis
• Conclusion
• Market Overview
• Evolution of RNA Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Nanoparticles
• Modified mRNA
• Market Analysis
• Takeaways
• COVID mRNA Vaccines
• Non-COVID mRNA Vaccines and Therapeutics
• Market Breakdown Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the mRNA Therapeutics Industry
• ESG Risk Ratings
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 7 Genome Editing: Technologies and Global Markets (BIO146D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Driver
• Market Restrains
• Market Opportunities
• Market Challenges
• Emerging Technologies
• In Vivo Delivery of CRISPR
• Market Breakdown
• CRISPR-Cas
• TALEN
• Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• Sustainability in Genome Editing: An ESG Perspective
• ESG Issues
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, and Gene Editing (BIO159B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• In Vivo Delivery of CRISPR
• Market Breakdown
• Key Takeaways
• RNA Therapy
• Gene-Modified Cell Therapy
• Gene Therapy
• Gene Editing
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• ESG Risk Ratings
• Conclusion

Chapter 9 Cell-Based Assays: Technologies and Global Markets (BIO080F)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• AI and Machine Learning (ML) in Data Analysis
• Market Breakdown
• Cell-based Assays: Global Markets
• Consumables
• Instruments
• Software
• Services
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Cell-based Assay Market
• Animal Testing
• Miniaturization and Automation
• Green Chemistry and Eco-friendly Materials
• 3D Cell Cultures and Tissue Models
• Waste Reduction and Optimization of Resources
• Improving Drug Discovery Efficiency
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 10 Appendix

• Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Market for DNA Read, Write, and Edit, by Region, Through 2030
• Table 2 : DNA Read, Write, and Edit Technology Overview
• Table 3 : Global Market for DNA Read, Write, and Edit, by Technology, Through 2030
• Table 4 : Global Market for DNA Read, Write, and Edit, by Region, Through 2030
• Table 5 : Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
• Table 6 : Social Performance Initiatives in the DNA Read, Write, and Edit Market
• Table 7 : Governance Performance Initiatives in the DNA Read, Write, and Edit Market
• Table 8 : ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
• Table 9 : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 10 : Chinese Market for DNA Sequencing, by Product and Service, Through 2030
• Table 11 : DNA Sequencing Instruments and Consumables Offered by Major Companies
• Table 12 : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 13 : Chinese Market for DNA Sequencing, by Province, Through 2030
• Table 14 : Global Market for DNA Forensics, by Region, Through 2030
• Table 15 : Crime Rates, by Country, 2024
• Table 16 : Global Market for DNA Forensics, by Product Type, Through 2030
• Table 17 : Global Market for DNA Forensics, by Source, Through 2030
• Table 18 : Global Market for DNA Forensics, by Technique, Through 2030
• Table 19 : Global Market for DNA Forensics, by Region, Through 2029
• Table 20 : ESG Rankings for Major DNA Forensics Companies, 2025*
• Table 21 : Global Market for Epigenetics Research Tools and Reagents, IVDs andTherapeutics, by Product Type, Through 2029
• Table 22 : Key Programs/Consortiums to Support Epigenetic Research
• Table 23 : Companies Developing Products Based on Epigenome Editing Platforms
• Table 24 : Global Market for Epigenetics Research Tools and Reagents, by Study Method, Through 2029
• Table 25 : Global Market for Epigenetic Research Tools and Reagents, IVDs and Therapeutics, by Region, Through 2029
• Table 26 : Key Sustainability Practices in the Pharmaceuticals Industry
• Table 27 : ESG Risk Ratings of Key Companies in the Epigenetics Market, 2024
• Table 28 : Ethos Impact Inc. Score Card for Key Companies in the Epigenetics Market, 2024
• Table 29 : Global Market for mRNA Therapeutics, by Disease, Through 2030
• Table 30 : Global Market for mRNA Therapeutics, by Disease Type, Through 2030
• Table 31 : Global Market for mRNA Therapeutics, by Region, Through 2030
• Table 32 : Focus Areas in ESG Metrics
• Table 33 : ESG Rankings for Major mRNA Therapeutics Companies, 2025*
• Table 34 : ESG: Environmental Overview
• Table 35 : ESG: Social Factors Overview
• Table 36 : ESG: Governance Overview
• Table 37 : Global Market for Genome Editing, by Technology, Through 2030
• Table 38 : Global Market for Genome Editing, by Technology, Through 2030
• Table 39 : Global Market for Genome Editing, by Region, Through 2030
• Table 40 : Bioethical Issues and Risks Associated with CRISPR Technology
• Table 41 : ESG Rankings for Genome Editing Companies, 2025*
• Table 42 : ESG: Environmental Overview
• Table 43 : ESG: Social Overview
• Table 44 : ESG: Governance Overview
• Table 45 : Global Market for Genetic Modification Therapies, by Region, Through 2030
• Table 46 : Global Market for Genetic Modification Therapies, by Platform Technology, Through 2030
• Table 47 : Approved CAR T-Cell Therapies
• Table 48 : Global Market for Genetic Modification Therapies, by Region, Through 2030
• Table 49 : Key Focus Areas in ESG Metrics
• Table 50 : ESG Risk Rankings for Genetic Modification Therapies Companies, 2025
• Table 51 : Global Market for Cell-based Assays, by Region, Through 2029
• Table 52 : Global Market for Cell-based Assays, by Product Type, Through 2029
• Table 53 : Global Market for Cell-based Assays, by Region, Through 2029
• Table 54 : ESG Rankings for Major Cell-based Assay Companies, 2024*

List of Figures

• Figure 1 : Global Market Shares of DNA Read, Write, and Edit, by Region, 2024
• Figure 2 : Global Market Shares of DNA Read, Write, and Edit, by Technology, 2024
• Figure 3 : Global Market Shares of DNA Read, Write, and Edit, by Region, 2024
• Figure 4 : Key ESG Metrics of DNA Read, Write, and Edit Companies
• Figure 5 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 6 : Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
• Figure 7 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 8 : Chinese Market Shares of DNA Sequencing, by Province, 2024
• Figure 9 : Global Market Shares of DNA Forensics, by Region, 2024
• Figure 10 : Global Market Shares of DNA Forensics, by Product Type, 2024
• Figure 11 : Global Market Shares of DNA Forensics, by Source, 2024
• Figure 12 : Global Market Shares of DNA Forensics, by Technique, 2024
• Figure 13 : Global Market Shares of DNA Forensics, by Region, 2024
• Figure 14 : Global Market Shares of Epigenetics Research Tools and Reagents, IVDs andTherapeutics, by Product Type, 2023
• Figure 15 : Global Market Shares of Epigenetics Research Tools and Reagents, by Study Method, 2023
• Figure 16 : Global Market Shares of Epigenetic Research Tools and Reagents, IVDs and Therapeutics, by Region, 2023
• Figure 17 : Selected Factors Driving ESG
• Figure 18 : Global Market Shares of mRNA Therapeutics, by Disease, 2024
• Figure 19 : Global Market Shares of mRNA Therapeutics, by Disease Type, 2024
• Figure 20 : Global Market Shares of mRNA Therapeutics, by Region, 2024
• Figure 21 : How a Strong ESG Proposition Can Benefit Businesses
• Figure 22 : Global Market Shares of Genome Editing, by Technology, 2024
• Figure 23 : Global Market Shares of Genome Editing, by Technology, 2024
• Figure 24 : Global Market Shares of Genome Editing, by Region, 2024
• Figure 25 : ESG Pillars
• Figure 26 : Advantages of ESG
• Figure 27 : Global Market Shares of Genetic Modification Therapies, by Region, 2024
• Figure 28 : Global Market Shares of Genetic Modification Therapies, by Platform Technology, 2024
• Figure 29 : Global Market Shares of Genetic Modification Therapies, by Region, 2024
• Figure 30 : Global Market Shares of Cell-based Assays, by Product Type, 2023
• Figure 31 : Global Market Shares of Cell-based Assays, by Region, 2023